A study published in PMC on oxidative stress in Graves' disease found that: *Hyperthyroidism is associated with increased lipid peroxidation products in thyroid and liver tissue *Glutathione peroxidase activity is upregulated in an attempt to compensate for increased ROS generation - but this compensatory response is often insufficient, leading to net oxidative damage *Antioxidant treatment may help counter some of the clinical manifestations of thyrotoxicosis by reducing ROS-driven cellular damage A review in PMC on oxidative stress in Graves' disease concluded: "These data suggest that increased ROS generation may contribute to generate some clinical manifestations of thyrotoxicosis and that antioxidant treatment may be beneficial." Selenium supplementation - acting through GPx and the glutathione system - has been shown to delay disease progression and improve quality of life in patients with Graves' orbitopathy (the eye complication of Graves' disease), as confirmed by the Frontiers in Endocrinology review
Consult a healthcare provider before use if pregnant or nursing
Moreover, another research group also found that TBK1 could phosphorylate selective autophagy receptors optineurin (OPTN), NDP52, and TAX1BP1 linking ubiquitinated cargo to autophagic membranes (106)
For example, if the objective is toxin elimination, the patient can undergo the detoxification therapy once a week
TMP has been reported to effectively attenuate hepatic I/R injury by inhibiting neutrophil extracellular trap formation and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Liu et al., 2021)
such screening should include a detailed psychiatric history, including a family history of suicide, Bipolar Disorder, and depression
